Amgen vs Eli Lilly (AMGN vs LLY)
Amgen (AMGN) vs Eli Lilly (LLY) in plain English: P/E, growth, margins, debt and dividend side by side, key differences and which fits each investor profile.
Amgen (AMGN) and Eli Lilly (LLY) compete in healthcare and pharma. Here are Amgen and Eli Lilly side by side with their real figures as of November 4, 2026: what sets them apart, which fits each kind of investor and the most common questions, without telling you whether to buy Amgen or Eli Lilly.
Amgen vs Eli Lilly: the figures
| Figure | Amgen | Eli Lilly |
|---|---|---|
| Share price | $478.48 (November 4, 2026) | $1,417.99 (November 4, 2026) |
| Market cap | $258.7 billion | $1.26 trillion |
| P/E (TTM) | 29.7x | 46.0x |
| Forward P/E | 19.5x | 28.3x |
| Revenue growth (quarter) | +9.5% | +38.6% |
| Net margin (TTM) | 23.0% | 31.9% |
| Net debt / EBITDA | 2.5x | 1.0x |
| Dividend yield | 2.19% | 0.49% |
| Beta | 0.42 | 0.39 |
Amgen and Eli Lilly figures from Yahoo Finance, the same source the Fintols analysis uses, retrieved on November 4, 2026; N/A means that Amgen or Eli Lilly figure is not available, and we never estimate it.
3 key differences between Amgen and Eli Lilly
- Growth: Eli Lilly grew sales +38.6% year on year in its latest quarter, against +9.5% for Amgen.
- Valuation: Eli Lilly trades at 46.0x its annual earnings and Amgen at 29.7x; the market pays more for each dollar of Eli Lilly profit, usually because it expects more growth.
- Profitability: for every 100 of sales, Eli Lilly keeps 31.9 as net profit and Amgen keeps 23.0.
Amgen or Eli Lilly: which fits your profile
- If you want growth: Eli Lilly is growing faster today, so it fits better with investors who put business growth first, usually accepting a higher P/E and a bumpier ride.
- If you want income (dividends): Amgen pays the higher dividend relative to its price.
- If you prefer caution: Eli Lilly has less debt relative to its profit, which usually gives more room in a bad year.
- If price is what matters most to you: Amgen trades on the lower P/E; check first whether that is an opportunity or a sign of a business that grows less.
Neither Amgen nor Eli Lilly wins on everything, and owning both is also an option: spreading money across several companies or an index fund reduces what rides on each one.
How Amgen and Eli Lilly make money
Amgen (AMGN)
Amgen is a biotech that sells branded medicines such as Repatha for cholesterol, Prolia and Evenity for bone health, Enbrel and Tezspire for inflammation, and Tepezza and Krystexxa for rare diseases, along with biosimilars. It reports a single segment, and the United States accounts for most of its sales. Full Amgen analysis.
Eli Lilly (LLY)
Eli Lilly sells prescription medicines. Its largest revenue source is tirzepatide, sold as Mounjaro for diabetes and Zepbound for obesity, followed by Verzenio for breast cancer, Jardiance and Trulicity for diabetes, Taltz for immunology and Kisunla for Alzheimer's disease. The United States is its biggest market. Full Eli Lilly analysis.
Frequently asked questions: Amgen vs Eli Lilly
Is Amgen or Eli Lilly the better stock?
Choosing between Amgen and Eli Lilly depends on what you are looking for. Eli Lilly is growing faster right now, and Amgen trades on the lower P/E. Fintols does not tell you whether to buy Amgen or Eli Lilly: it shows you the differences so you can decide.
Which pays a higher dividend, Amgen or Eli Lilly?
As of November 4, 2026, Amgen yields 2.19% and Eli Lilly yields 0.49%. Also check how much of their profit Amgen and Eli Lilly pay out: if it is more than they earn, it cannot last.
Which is more expensive, Amgen or Eli Lilly?
On P/E, Eli Lilly (46.0x) is more expensive than Amgen (29.7x) as of November 4, 2026. A higher P/E can be justified if earnings grow faster, so compare it with each company's growth in the table.
Can I own both Amgen and Eli Lilly?
Yes. Many people spread their money across several companies, such as Amgen and Eli Lilly, or use index funds so they do not depend on just one. If you are starting out, decide how much you want to invest and for how long before buying Amgen or Eli Lilly.
More comparisons with Amgen or Eli Lilly
More companies like Amgen and Eli Lilly: healthcare and pharma stocks. Educational content about Amgen and Eli Lilly, not investment advice.